Thanks Greg and good morning, everyone. Let's turn to the earnings highlights on Slide 5. Reported second quarter earnings per share was $0.48 compared to $4.09 in the second quarter of 2023. Reported results included an unfavorable mark-to-market timing difference of $0.82 per share and a negative impact of $0.43 per share related to transaction and integration costs associated with our announced business combination with Viterra. Adjusted EPS was $1.73 in the quarter versus $3.72 in the prior year. Adjusted core segment earnings before interest and taxes, or EBIT, was $519 million in the quarter, which is $893 million last year. Agribusiness, processing results of $265 million in the quarter or down from last year as higher results in Europe soy and soft seed crush, but more than offset by lower results in North and South America and Asia. Merchandising, lower results were primarily driven by global grains. Our volumes were more than offset by lower margins. Refined and specialty oils performed well, but down from a strong prior year. Higher results in Asia were more than offset by lower results in North and South America and Europe. Milling, higher results were primarily driven by South America, reflecting higher volumes and margins, both [ph] in the U.S. were in line with the prior year. Corporate and other improved from last year. The decrease in corporate expenses is largely due to lower performance-based compensation. Our results in other were primarily related to our Captive insurance program. In our non-core sugar and bioenergy joint venture, core results were due to lower Brazil ethanol prices, which more than offset higher sugar prices. Results were also negatively impacted by approximately $15 million in foreign exchange translation losses with U.S. dollar-denominated debt. Results in the prior year included a $39 million benefit, reversal of a tax valuation allowance. The first six months of the year, reported income tax expense was $147 million compared to $381 million in the prior year. The decrease is primarily due to lower pre-tax income. Net interest expense of $86 million in the quarter was in line with last year. Let's turn to Slide 6, where you can see adjusted EPS and EBIT trend over the past four years, along with the trailing 12 months. Strong performance over the period reflects a combination of favorable market environment and full execution by our team. The more recent trend reflects more balanced and less volatile markets, translating into lower earnings. Slide 7 details our capital allocation. First half of the year, we generated $895 million of adjusted funds from operations. After allocating $191 million to sustaining CapEx, which includes maintenance, environmental, health, and safety, we had $704 million of discretionary cash flow available. Of this amount, we paid $191 million in dividends, invested $342 million in growth in productivity related CapEx, half of which relates to our large multiyear greenfield investments, and repurchased $400 million of Bunge shares. This resulted in a use of $229 million of previously retained cash flow. We are in progress on our greenfield products. We could end the year with the higher end of our CapEx range of $1.2 billion to $1.4 billion, or perhaps slightly above. However, this would reduce our 2025 expectations. Moving to Slide 8. Quarter end readily marketable inventories, or RMI, exceeded our net debt by approximately $3 billion. Our adjusted leverage ratio, which reflects our adjusted net debt to adjusted EBITDA, was 0.5 times at the end of the quarter. Slide 9 highlights our liquidity position. At quarter end, we have committed credit facilities of approximately $8.7 billion, which includes $3 billion that will become available to draw upon at the close of the Viterra transaction. With the $5.7 billion available to us currently, all was unused at the end of the quarter, providing sample liquidity to manage on our ongoing capital needs. These amounts are in addition to the $8 billion of term loan commitments that we have secured to fund the Viterra transaction. Please turn to Slide 10. Trailing 12 months adjusted ROIC was 15.2%, well above our RMI adjusted weighted average cost of capital of 7.7%. ROIC was 12.2%, well above our weighted average cost of capital of 7%. Moving to Slide 11. For the trailing 12 months, we produced discretionary cash flow approximately $1.5 billion, a cash flow yield of 13.7% compared to our cost of equity at 8.2%. Please turn to Slide 12 and our 2024 outlook. As Greg mentioned in his remarks, taking into account first half results and the current margin environment forward curves, we now expect full year 2024 adjusted EPS of approximately $9.25. Note that this forecast excludes any pending transactions that are expected to close during the year. In the Agribusiness, full year results are forecasted to be in line with our previous outlook, reflecting higher results and processing, largely offset by lower results in merchandising. Notes [ph] are expected to be down compared to last year. The refined and specialty oils full year results are expected to be up from our previous outlook, due to a better-than-expected second quarter, but down compared to last year's record performance. The milling, full year results are expected to be similar to our previous outlook and up from last year. In corporate and other, full year results are expected to be similar to our previous outlook. In non-core, full year results in our sugar and bioenergy joint venture are expected to be down slightly from our previous outlook and down significantly last year. Additionally, company expects the following for 2024; adjusted annual effective tax rate of 22% to 25%; net interest expense in the range of $280 million to $310 million; capital expenditures in the range of $1.2 billion to $1.4 billion, as I mentioned earlier; and depreciation and amortization of approximately $450 million. With that, I'll turn things back over to Greg for some closing comments.